4-bromo-3,5,7-trideuterio-1-(2,5-dideuterio-3-fluoro-4-phenylmethoxyphenyl)indazole-6-carbonitrile
C21H13BrFN3O — CID 91249770
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-bromo-3,5,7-trideuterio-1-(2,5-dideuterio-3-fluoro-4-phenylmethoxyphenyl)indazole-6-carbonitrile
4-bromo-3,5,7-trideuterio-1-(2,5-dideuterio-3-fluoro-4-phenylmethoxyphenyl)indazole-6-carbonitrile (PubChem CID 91249770) has the molecular formula C21H13BrFN3O and a molecular weight of 427.29 g/mol. Its IUPAC name is 4-bromo-3,5,7-trideuterio-1-(2,5-dideuterio-3-fluoro-4-phenylmethoxyphenyl)indazole-6-carbonitrile.
Molecular Properties
| Compound Name | 4-bromo-3,5,7-trideuterio-1-(2,5-dideuterio-3-fluoro-4-phenylmethoxyphenyl)indazole-6-carbonitrile |
|---|---|
| PubChem CID | 91249770 |
| Molecular Formula | C21H13BrFN3O |
| Molecular Weight | 427.29 g/mol |
| Exact Mass | 426.05 |
| IUPAC Name | 4-bromo-3,5,7-trideuterio-1-(2,5-dideuterio-3-fluoro-4-phenylmethoxyphenyl)indazole-6-carbonitrile |
| SMILES | [2H]c1cc(-n2nc([2H])c3c(Br)c([2H])c(C#N)c([2H])c32)c([2H])c(F)c1OCc1ccccc1 |
| InChI | InChI=1S/C21H13BrFN3O/c22-18-8-15(11-24)9-20-17(18)12-25-26(20)16-6-7-21(19(23)10-16)27-13-14-4-2-1-3-5-14/h1-10,12H,13H2/i7D,8D,9D,10D,12D |
| InChIKey | BQHNYASHZNJXNZ-NQRALGTCSA-N |
| XLogP | 5.38 |
| TPSA | 50.84 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 27 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 427.29 |
| LogP ≤ 5 | 5.38 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 91249770 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.